Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Olfactomedin 4 inhibits cathepsin C-mediated protease activities, thereby modulating neutrophil killing of Staphylococcus aureus and Escherichia coli in mice.

Liu W, Yan M, Liu Y, McLeish KR, Coleman WG Jr, Rodgers GP.

J Immunol. 2012 Sep 1;189(5):2460-7. doi: 10.4049/jimmunol.1103179. Epub 2012 Jul 27.

2.

Therapeutic utility and medicinal chemistry of cathepsin C inhibitors.

Guay D, Beaulieu C, Percival MD.

Curr Top Med Chem. 2010;10(7):708-16. Review.

PMID:
20337582
3.

How methicillin-resistant Staphylococcus aureus evade neutrophil killing.

Greenlee-Wacker M, DeLeo FR, Nauseef WM.

Curr Opin Hematol. 2015 Jan;22(1):30-5. doi: 10.1097/MOH.0000000000000096. Review.

4.

Neutrophils versus Staphylococcus aureus: a biological tug of war.

Spaan AN, Surewaard BG, Nijland R, van Strijp JA.

Annu Rev Microbiol. 2013;67:629-50. doi: 10.1146/annurev-micro-092412-155746. Epub 2013 Jul 3. Review.

PMID:
23834243
5.
6.

Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers.

Guette C, Valo I, Vétillard A, Coqueret O.

Proteomics Clin Appl. 2015 Feb;9(1-2):58-63. doi: 10.1002/prca.201400083. Epub 2014 Dec 28. Review.

PMID:
25400027
Items per page

Supplemental Content

Write to the Help Desk